Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Morel

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Molecular Cancer|July 8, 2011
Irinotecan induces steroid and xenobiotic receptor (SXR) signaling to detoxification pathway in colon cancer cellsAgnes Basseville, Laurence Preisser, Sophie de Carné Trécesson, et al.
Clinical Therapeutics|March 2, 2006
Clinical and laboratory safety of one year's use of a combination calcium + vitamin D tablet in ambulatory elderly women with vitamin D insufficiency: results of a multicenter, randomized, double-blind, placebo-controlled studyMichel Brazier, Franck Grados, Saïd Kamel, et al.
Drug and Alcohol Dependence|November 26, 2013
Predictors of non-prescribed opioid use after one year of methadone treatment: an attributable-risk approach (ANRS-Methaville trial)Caroline Lions, M Patrizia Carrieri, Laurent Michel, et al.
British Journal of Clinical Pharmacology|July 27, 2010
Lethal outcome of 5-fluorouracil infusion in a patient with a total DPD deficiency and a double DPYD and UTG1A1 gene mutationHélène Mounier-Boutoille, Michèle Boisdron-Celle, Estelle Cauchin, et al.
Clinical Lung Cancer|September 22, 2021
A Case Report of Successful Treatment With Crizotinib to Overcome Resistance to Osimertinib in an EGFR Mutated Non-Small-Cell Lung Cancer Patient Harboring an Acquired MET Exon 14 MutationFrançois Pinquie, Alexis B Cortot, Louise-Marie Chevalier, et al.
Journal of Substance Abuse Treatment|August 12, 2015
Variations in Cannabis Use Level and Correlates in Opiate-Users on Methadone Maintenance Treatment: A French Prospective StudyAurélie Mayet, Caroline Lions, Perrine Roux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2008
Oxaliplatin-related neurotoxicity: interest of calcium-magnesium infusion and no impact on its efficacyLaurence Gamelin, Michèle Boisdron-Celle, Alain Morel, et al.
Comprehensive Psychiatry|September 8, 2015
Suicidal risk among patients enrolled in methadone maintenance treatment: HCV status and implications for suicide prevention (ANRS Methaville)Laurent Michel, Caroline Lions, Gwenaelle Maradan, et al.
The International Journal on Drug Policy|October 23, 2016
Decrease in self-reported offences and incarceration rates during methadone treatment: A comparison between patients switching from buprenorphine to methadone and maintenance treatment incident users (ANRS-Methaville trial)Patrizia Carrieri, Antoine Vilotitch, Sandra Nordmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Predictive factors of oxaliplatin neurotoxicity: the involvement of the oxalate outcome pathwayLaurence Gamelin, Olivier Capitain, Alain Morel, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Molecular Cancer|July 8, 2011
Irinotecan induces steroid and xenobiotic receptor (SXR) signaling to detoxification pathway in colon cancer cellsAgnes Basseville, Laurence Preisser, Sophie de Carné Trécesson, et al.
Clinical Therapeutics|March 2, 2006
Clinical and laboratory safety of one year's use of a combination calcium + vitamin D tablet in ambulatory elderly women with vitamin D insufficiency: results of a multicenter, randomized, double-blind, placebo-controlled studyMichel Brazier, Franck Grados, Saïd Kamel, et al.
Drug and Alcohol Dependence|November 26, 2013
Predictors of non-prescribed opioid use after one year of methadone treatment: an attributable-risk approach (ANRS-Methaville trial)Caroline Lions, M Patrizia Carrieri, Laurent Michel, et al.
British Journal of Clinical Pharmacology|July 27, 2010
Lethal outcome of 5-fluorouracil infusion in a patient with a total DPD deficiency and a double DPYD and UTG1A1 gene mutationHélène Mounier-Boutoille, Michèle Boisdron-Celle, Estelle Cauchin, et al.
Clinical Lung Cancer|September 22, 2021
A Case Report of Successful Treatment With Crizotinib to Overcome Resistance to Osimertinib in an EGFR Mutated Non-Small-Cell Lung Cancer Patient Harboring an Acquired MET Exon 14 MutationFrançois Pinquie, Alexis B Cortot, Louise-Marie Chevalier, et al.
Journal of Substance Abuse Treatment|August 12, 2015
Variations in Cannabis Use Level and Correlates in Opiate-Users on Methadone Maintenance Treatment: A French Prospective StudyAurélie Mayet, Caroline Lions, Perrine Roux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 4, 2008
Oxaliplatin-related neurotoxicity: interest of calcium-magnesium infusion and no impact on its efficacyLaurence Gamelin, Michèle Boisdron-Celle, Alain Morel, et al.
Comprehensive Psychiatry|September 8, 2015
Suicidal risk among patients enrolled in methadone maintenance treatment: HCV status and implications for suicide prevention (ANRS Methaville)Laurent Michel, Caroline Lions, Gwenaelle Maradan, et al.
The International Journal on Drug Policy|October 23, 2016
Decrease in self-reported offences and incarceration rates during methadone treatment: A comparison between patients switching from buprenorphine to methadone and maintenance treatment incident users (ANRS-Methaville trial)Patrizia Carrieri, Antoine Vilotitch, Sandra Nordmann, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2007
Predictive factors of oxaliplatin neurotoxicity: the involvement of the oxalate outcome pathwayLaurence Gamelin, Olivier Capitain, Alain Morel, et al.
Pageof 7